Analyst Ratings for Arbutus Biopharma (ABUS)
ABUS Rating Summary
ABUS Price Target Summary
- Highest: $5.00 (Chardan)
- Lowest: $5.00 (Chardan)
- Average: $5.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$5.00 (+10.4%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/2/2022 | Jefferies | Dennis Ding | Upgrade | Buy (Hold) |
5.00 (4.00) |
2.81 (4.53) |
61.21% | Details |
| 12/17/2020 | H.C. Wainwright » Updated 11/10/2022 |
Ed Arce | New Coverage | Buy (N/A) |
6.00 (7.50) |
4.41 (4.53) |
2.72% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
